Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice

Microbiology and Immunology

Volumn 56, Issue 6, 2012, Pages 406-410

  Yi, Shao Qiong ^a   Zhang, Xiao Yan ^a   Yang, Yi Long ^a   Yang, Yue ^a   Liu, Shu Ling ^a   Fu, Ling ^a   Yu, Chang Ming ^a   Chen, Wei ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

SasA; Staphylococcus aureus; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; SODIUM CHLORIDE; STAPHYLOCOCCUS PROTEIN A; STAPHYLOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; INFECTION PREVENTION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL PROTEINS; FEMALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS;

EID: 84862249295     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00451.x     Document Type: Article

References (20)

1. Lowry F.D. (1998) Staphylococcus aureus infections. New Engl J Med 339: 520-32.
2. Solomon S., Horan T., Andrus M., Edwards J., Fridkin S., Koganti J., Peavy G., Tolson J. (2003) National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 31: 481-98.
3. Pfaller M.A., Jones R.N., Doern G.V., Kugler K. (1998) Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 42: 1762-70.
4. Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J., Bell J., Jones R.N., Beach M. (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32: S114-32.
5. Diekema D.J., Pfaller M.A., Jones R.N. (2002) Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America. SENTRY Antimicrobial Surveillance Program, 1997-2000. Int J Antimicrob Agents 20: 412-8.
6. Lowy F.D. (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111: 1265-73.
7. Moore M.R., Perdreau-Remington F., Chambers H.F. (2003) Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother 47: 1262-6.
8. Grabs A.J., Lord R.S. (2002) Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J 176: 563.
9. Fattom A.I., Horwith G., Fuller S., Propst M., Naso R. (2004) Development of StaphVAX™, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Vaccine 22: 880-7.
10. Maira-Litran T., Kropec A., Goldmann D., Pier G.B. (2004) Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine 22: 872-9.
11. Hall A.E., Domanski P.J., Patel P.R., Vernachio J.H., Syribeys P.J., Gorovits E.L., Johnson M.A., Ross J.M., Hutchins J.T., Patti J.M. (2003) Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A. Infect Immun 71: 6864-70.
12. Schaffer A.C., Solinga R.M., Cocchiaro J., Portoles M., Kiser K.B., Risley A., Randall S.M., Valtulina V., Speziale P., Walsh E., Foster T., Lee J.C. (2006) Immunization with Staphylococcus aureus Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces NasalColonization in a Murine Model. Infect Immun 74: 2145-53.
13. Torres V.J., Pishchany G., Humayun M., Schneewind O., Skaar E.P. (2006) Staphylococcus aureus IsdB Is a Hemoglobin Receptor Required for Heme Iron Utilization. J Bacteriol 188: 8421-9.
14. Ahmed S., Meghji S., Williams R.J., Henderson B., Brock J.H., Nair S.P. (2001) Staphylococcus aureus Fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intra-cellular levels of bacteria. Infect Immun 69(5): 2872-7.
15. Stranger-Jones Y.K., Bae T., Schneewind O. (2006) Vaccine assembly from surface proteins of Staphylococcus aureus. PNAS 103: 16942-7.
16. Li F., Chai J., Chang D. (2006) A control study on bacterial resistance and clinical features of wound infection in burned patients in intensive care unit and general ward. Chinese J Nosocomiology 16: 1069-71.
17. Colque-Navarro P., Palma M., Söderquist B., Flock J.I., Möllby R. (2000) Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol 7: 14-20.
18. Ian R.S., Henry F.C., Paul M.S. (2005) Role of SraP, a serine-rich surface protein of Staphylococcus aureus, in binding to human platelets. Infect immune 73: 2273-80.
19. Casolini F., Visai L., Joh D., Conaldi P.G., Toniolo A. Höök M., Speziale P. (1998) Antibody response to fibronectin-binding adhesin FnbpA in patients with Staphylococcus aureus infections. Infect Immun 66: 5433-42.
20. Rindi S., Cicalini S., Pietrocola G., Venditti M., Festa A., Foster T.J., Petrosillo N., Speziale P. (2006) Antibody response in patients with endocarditis caused by Staphylococcus aureus. Eur J Clin Invest 36: 536-43.